The Cancer Profiling Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Cancer Profiling Market?
The Cancer Profiling market has experienced significant growth in recent years. The market size is predicted to escalate from $13.48 billion in 2024 to $15.05 billion in 2025 with a compound annual growth rate (CAGR) of 11.6%. The historical growth trend in the Cancer Profiling market has been rapidly increasing.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Cancer Profiling Industry?
The Cancer Profiling market is estimated to rise to a value of $23.08 billion by the year 2029, progressing at a compound annual growth rate (CAGR) of 11.3%.
Download Your Free Sample of the 2025 Cancer Profiling Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Cancer Profiling Market?
The key drivers in the cancer profiling market are:
• Integration of artificial intelligence in cancer profiling
• Global collaborations in cancer research
• Expansion of liquid biopsy applications in cancer profiling
• Regulatory support for precision medicine and emphasis on early detection
Global Market Segmentation: Identifying Major Cancer Profiling Industry Segments
The cancer profiling market covered in this report is segmented –
1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization
2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers
4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications
Pre-order the 2025 Cancer Profiling Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Cancer Profiling Market?
The key trends in the cancer profiling market are:
• The integration of artificial intelligence is shaping the future of the Cancer Profiling market.
• Liquid biopsy applications are expanding and dominating the market.
• There is an increasing global collaboration in cancer research.
• Single-cell sequencing is emerging as a significant trend in the market.
Who Are the Top Competitors & Leading Players in the Cancer Profiling Market?
Major companies in the cancer profiling market are:
• Illumina Inc.
• Qiagen NV
• NeoGenomics Inc.
• Sysmex Corporation
• HTG Molecular Diagnostics Inc.
• Caris Life Sciences
• NanoString Technologies Inc.
• Guardant Health Inc.
• Foundation Medicine Inc.
• Roche Diagnostics Corporation
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Genscript Biotech Corporation
• Tempus Labs Inc.
• Hologic Inc.
• Predictive Oncology Inc.
• Abbott Laboratories
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Siemens Healthineers
• Genomic Health Inc.
• Natera Inc.
• ArcherDX Inc.
• Personal Genome Diagnostics Inc.
• Enzo Biochem Inc.
• Cancer Genetics Inc.
• OncoDNA SA
• Ribomed Biotechnologies Inc.
• Biocartis Group NV
• N-of-One Inc.
• Cynvenio Biosystems Inc.
• Inivata Ltd.
• Burning Rock Biotech Limited
• PathAI Inc.
• GENEWIZ Inc.
• Genoptix Inc.
• Oncomine Dx Target Test
• OmniSeq Comprehensive
• Resolution Bioscience
• OncoCyte Corporation
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the cancer profiling market in 2024
